Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
49.04
-0.99 (-1.98%)
At close: May 15, 2026, 4:00 PM EDT
48.98
-0.06 (-0.12%)
After-hours: May 15, 2026, 7:58 PM EDT
Moderna Market Cap
Moderna has a market cap or net worth of $19.46 billion as of May 15, 2026. Its market cap has increased by 86.14% in one year.
Market Cap
19.46B
Enterprise Value
13.30B
1-Year Change
86.14%
Ranking
Category
Stock Price
$49.04
Market Cap Chart
Since December 7, 2018, Moderna's market cap has increased from $6.12B to $19.46B, an increase of 218.03%. That is a compound annual growth rate of 16.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 19.46B | 68.87% |
| Dec 31, 2025 | 11.52B | -27.99% |
| Dec 31, 2024 | 16.00B | -57.80% |
| Dec 29, 2023 | 37.92B | -45.05% |
| Dec 30, 2022 | 69.01B | -32.99% |
| Dec 31, 2021 | 102.98B | 149.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 7, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Royalty Pharma | 30.43B |
| Insmed | 23.66B |
| BioNTech SE | 22.65B |
| Roivant Sciences | 20.96B |
| Incyte | 19.04B |
| Genmab | 16.20B |
| Ascendis Pharma | 14.93B |
| Jazz Pharmaceuticals | 14.35B |